Literature DB >> 21143654

Role of astroglia in the neuroplastic and neuroprotective actions of estradiol.

Iñigo Azcoitia1, María Santos-Galindo, María A Arevalo, Luis M Garcia-Segura.   

Abstract

Astrocyte-neuron cross-talk is an essential component of the mechanisms involved in the neuroendocrine and neuroprotective actions of estradiol. Astrocytes express estrogen receptors, show morphological and functional modifications in response to estradiol and participate in the hormonal regulation of synaptic plasticity and neuroendocrine events. In addition, estradiol interferes with the activation of astrocytes under pathological conditions, modulating the release of neurotrophic factors and inflammatory molecules by these cells. Furthermore, under neurodegenerative conditions, astrocytes synthesize estradiol, which acts as a local neuroprotectant. The actions of estradiol on astrocytes can be imitated by selective estrogen receptor modulators. Some of these molecules, which are free of the peripheral risks associated with estrogen therapy, exert estradiol-like anti-inflammatory actions on astrocytes and are potential therapeutic candidates for the control of reactive astrogliosis.
© 2010 The Authors. European Journal of Neuroscience © 2010 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21143654     DOI: 10.1111/j.1460-9568.2010.07516.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  31 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  Depletion of Nrf2 enhances inflammation induced by oxyhemoglobin in cultured mice astrocytes.

Authors:  Hao Pan; Handong Wang; Lin Zhu; Lei Mao; Liang Qiao; Xingfen Su
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

Review 3.  Insights into rapid modulation of neuroplasticity by brain estrogens.

Authors:  Deepak P Srivastava; Kevin M Woolfrey; Peter Penzes
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

4.  Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats.

Authors:  Luciele Varaschini Teixeira; Roberto Farina Almeida; Francieli Rohden; Leo Anderson Meira Martins; Poli Mara Spritzer; Diogo Onofre Gomes de Souza
Journal:  Neurochem Res       Date:  2018-05-31       Impact factor: 3.996

Review 5.  Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging.

Authors:  Nioka C Chisholm; Farida Sohrabji
Journal:  Neurobiol Dis       Date:  2015-04-02       Impact factor: 5.996

6.  Estrogen receptor alpha is required in GABAergic, but not glutamatergic, neurons to masculinize behavior.

Authors:  Melody V Wu; Jessica Tollkuhn
Journal:  Horm Behav       Date:  2017-07-20       Impact factor: 3.587

Review 7.  Oestrogen signalling and neuroprotection in cerebral ischaemia.

Authors:  D Brann; L Raz; R Wang; R Vadlamudi; Q Zhang
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

8.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

Review 9.  Astrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in astrocytes.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Eunsook Lee
Journal:  Mol Cell Endocrinol       Date:  2014-01-18       Impact factor: 4.102

10.  Sex differences in glucoprivic regulation of glycogen metabolism in hypothalamic primary astrocyte cultures: Role of estrogen receptor signaling.

Authors:  Mostafa M H Ibrahim; Khaggeswar Bheemanapally; Paul W Sylvester; Karen P Briski
Journal:  Mol Cell Endocrinol       Date:  2020-08-25       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.